REGULATED INFORMATION

Courbevoie, France – October 07, 2026

Information on number of shares and voting rights as provided
by article 223-16 of the general regulations of the
French financial markets authority AMF

Issuer: Bureau Veritas

Date Number of shares (1) Number of voting rights
30/09/2026 453,899,720                 Theoretical number of voting rights: 579,456,124
                Number of exercisable voting rights: 569,351,911

(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2026, if any.
                

  

Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00
Société Anonyme Tour Alto Fax: + 33 (0)1 55 24 70 01
(Limited liability corporation) 4, Place des Saisons www.bureauveritas.com
Share capital of EUR 54,464,582.40 92400 Courbevoie  
RCS Nanterre 775 690 621 France  

Attachment

AB Akola Group publishes its audited consolidated and Company financial statements for the financial year 2025/2026 ended 30 June 2026, the consolidated management report, the independent practitioner’s limited assurance report on AB Akola Group’s consolidated sustainability report, and the independent auditor’s report on the Company’s consolidated financial statements. All these documents are attached to this announcement.

The audited consolidated and Company financial statements will be submitted for approval at the Annual General Meeting of Shareholders to be held on 28 October 2026.

Key financial indicators

The consolidated revenue of Akola Group for the financial year 2025/2026 exceeded EUR 1,5 billion but was 4% lower than in the corresponding period of the previous year. The Group sold 3,053 thousand tons of various products, or 2% less than in the same period last year. Gross profit decreased by 6% to EUR 182 million and operating profit decreased by 23% to EUR 61 million compared to the corresponding period. Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to EUR 95 million, 14% lower than during the same period in the previous year. Net profit decreased by 29% to EUR 43 million.

  2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Total trading volume, tons 3,116,339 3,053,397 (2.0)
Revenue, thousand EUR 1,580,699 1,511,274 (4.4)
Gross profit, thousand EUR 194,086 181,790 (6.3)
EBITDA, thousand EUR 110,219 95,108 (13.7)
Adjusted EBITDA, thousand EUR 110,713 95,460 (13.8)
Operating profit, thousand EUR 78,916 60,638 (23.2)
Net profit, thousand EUR 60,692 42,568 (29.9)


Partners for Farmers

In the 2025/2026 financial year, the Partnership with Farmers segment generated EUR 1,047 million in revenue, nearly EUR 80 million in gross profit and EUR 9 million in operating profit.

Partners for Farmers 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 1,151,737 1,046,834 (9.1)
Gross profit, thousand EUR 92,088 79,719 (13.4)
Operating profit, thousand EUR 28,930 9,030 (68.8)


Food Production

In the 2025/2026 financial year, the Food Production segment generated EUR 482 million in revenue, an increase of 7% year-on-year, while gross profit reached EUR 99 million and operating profit increased by almost half to EUR 57 million.

Food Production 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 449,134 482,430 7.4
Gross profit, thousand EUR 84,949 99,083 16.6
Operating profit, thousand EUR 39,170 57,148 45.9


Farming

In the 2025/2026 financial year, the Farming segment generated EUR 43 million in revenue, while gross profit amounted to EUR 92 thousand and the operating loss stood at EUR 1.4 million.

Farming 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 47,682 42,844 (10.2)
Gross profit, thousand EUR 12,977 92 (99.3)
Operating profit, thousand EUR 11,260 (1,431) (112.7)


Other Products and Services

In the 2025/2026 financial year, the Other Products and Services segment generated EUR 22 million in revenue, with gross profit of EUR 3 million and an operating loss of EUR 4 million.

Other products and services 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 20,844 21,999 5.5
Gross profit, thousand EUR 4,069 2,897 (28.8)
Operating profit, thousand EUR (444) (4,109) (825.5)

AB Akola Group is the largest agribusiness and food production group in the Baltics, employing over 5,000 people The group includes such well-known companies as Kauno grūdai, Linas Agro, Vilniaus paukštynas, Kaišiadorių paukštynas, Dotnuva Baltic, and others. The Group operates throughout the entire food production chain, “from field to fork”.

For more information:

Mažvydas Šileika
Deputy CEO for Finance and Investments at AB Akola Group
E-mail m.sileika@akolagroup.lt
Mob. +370 619 19 403

Attachments

AB Akola Group publishes its audited consolidated and Company financial statements for the financial year 2025/2026 ended 30 June 2026, the consolidated management report, the independent practitioner’s limited assurance report on AB Akola Group’s consolidated sustainability report, and the independent auditor’s report on the Company’s consolidated financial statements. All these documents are attached to this announcement.

The audited consolidated and Company financial statements will be submitted for approval at the Annual General Meeting of Shareholders to be held on 28 October 2026.

Key financial indicators

The consolidated revenue of Akola Group for the financial year 2025/2026 exceeded EUR 1,5 billion but was 4% lower than in the corresponding period of the previous year. The Group sold 3,053 thousand tons of various products, or 2% less than in the same period last year. Gross profit decreased by 6% to EUR 182 million and operating profit decreased by 23% to EUR 61 million compared to the corresponding period. Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to EUR 95 million, 14% lower than during the same period in the previous year. Net profit decreased by 29% to EUR 43 million.

  2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Total trading volume, tons 3,116,339 3,053,397 (2.0)
Revenue, thousand EUR 1,580,699 1,511,274 (4.4)
Gross profit, thousand EUR 194,086 181,790 (6.3)
EBITDA, thousand EUR 110,219 95,108 (13.7)
Adjusted EBITDA, thousand EUR 110,713 95,460 (13.8)
Operating profit, thousand EUR 78,916 60,638 (23.2)
Net profit, thousand EUR 60,692 42,568 (29.9)


Partners for Farmers

In the 2025/2026 financial year, the Partnership with Farmers segment generated EUR 1,047 million in revenue, nearly EUR 80 million in gross profit and EUR 9 million in operating profit.

Partners for Farmers 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 1,151,737 1,046,834 (9.1)
Gross profit, thousand EUR 92,088 79,719 (13.4)
Operating profit, thousand EUR 28,930 9,030 (68.8)


Food Production

In the 2025/2026 financial year, the Food Production segment generated EUR 482 million in revenue, an increase of 7% year-on-year, while gross profit reached EUR 99 million and operating profit increased by almost half to EUR 57 million.

Food Production 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 449,134 482,430 7.4
Gross profit, thousand EUR 84,949 99,083 16.6
Operating profit, thousand EUR 39,170 57,148 45.9


Farming

In the 2025/2026 financial year, the Farming segment generated EUR 43 million in revenue, while gross profit amounted to EUR 92 thousand and the operating loss stood at EUR 1.4 million.

Farming 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 47,682 42,844 (10.2)
Gross profit, thousand EUR 12,977 92 (99.3)
Operating profit, thousand EUR 11,260 (1,431) (112.7)


Other Products and Services

In the 2025/2026 financial year, the Other Products and Services segment generated EUR 22 million in revenue, with gross profit of EUR 3 million and an operating loss of EUR 4 million.

Other products and services 2024/2025 2025/2026 2025/2026
compared with
2024/2025, %
Revenue, thousand EUR 20,844 21,999 5.5
Gross profit, thousand EUR 4,069 2,897 (28.8)
Operating profit, thousand EUR (444) (4,109) (825.5)

AB Akola Group is the largest agribusiness and food production group in the Baltics, employing over 5,000 people The group includes such well-known companies as Kauno grūdai, Linas Agro, Vilniaus paukštynas, Kaišiadorių paukštynas, Dotnuva Baltic, and others. The Group operates throughout the entire food production chain, “from field to fork”.

For more information:

Mažvydas Šileika
Deputy CEO for Finance and Investments at AB Akola Group
E-mail m.sileika@akolagroup.lt
Mob. +370 619 19 403

Attachments

Reykjavík, Oct. 07, 2026 (GLOBE NEWSWIRE) —

(“Amaroq” or the “Company“)

Admission to Trading and PDMR Transaction

07 October 2026 – Amaroq Ltd. (LSE and NASDAQ Iceland: AMRQ, OTCQX: AMRQF), an independent mine development company focused on unlocking Greenland’s mineral potential, announces that, in accordance with the Financial Conduct Authority’s Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, the following shares have been admitted to trading:

Issuer name:  Amaroq Ltd.
Issuer LEI:  213800Q21S5JQ6WKCE70
Regulated market on which the shares have been admitted to trading: Main Market for listed securities of the London Stock Exchange
Name, type and ISIN of the shares:
 
Common shares of no par value
ISIN: CA02311U1030
Number of further shares admitted to trading covered by the notification: 147,879
Total number of shares admitted to trading (including the new shares):  466,392,011
Confirmation that the new shares are fungible with existing shares already admitted to trading:  Confirmed
Date range covered by the notification: 1 September 2026 to 6 October 2026

DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

The Company has been informed by Non-Executive Director Graham Stewart, that for personal reasons he has had to dispose of 1,000,000 shares. Graham remains a large shareholder, with 1,982,537 shares. Please find further detail below:

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name: Graham Stewart
2. Reason for the notification
a) Position/status: Non-Executive Director
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Amaroq Ltd.
b) LEI: 213800Q21S5JQ6WKCE70
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument:
Identification code:
Common shares of no par value in Amaroq Ltd.
ISIN: CA02311U1030
b) Nature of the transaction: Sale of common shares of no par value in Amaroq Ltd.
c) Price(s) and volume(s):            Price(s)         Volume(s)
121.5p                        1,000,000
d) Aggregated information:

  • Aggregated volume:
  • Average price:
            1,000,000
121.5p
e) Date of the transaction(s): 6 October 2026
f) Place of the transaction London Stock Exchange (XLON)

Enquiries:
Amaroq Ltd. C/O
Ed Westropp, Chief Corporate Development and Strategy Officer
+44 (0)7385 755711
ewe@amaroqminerals.com

Canaccord Genuity Limited (Corporate Broker)
James Asensio
Rory Blundell
Harry Rees
+44 (0) 20 7523 8000

Citigroup Global Markets (Corporate Broker)
Andrew Miller-Jones
David Herring
+44 (0) 207 986 3463

Panmure Liberum Limited (Corporate Broker)
Scott Mathieson
Piers Shimwell
+44 (0) 20 7886 2500

Camarco (Financial PR)
Elfie Harkell
Rebecca Waterworth
Charlie Ramos
+44 (0) 20 3757 4980

Further Information:

About Amaroq

Amaroq’s focus is the identification, acquisition, exploration and development of gold and strategic metals in Greenland. The Company’s principal asset is the 100% owned and operated, producing Nalunaq Gold mine.

Amaroq’s significant exploration portfolio includes opportunities in gold, copper, nickel, and rare earth elements across South Greenland as well as zinc, lead, silver, germanium and gallium at its West Greenland Hub centred on the past-producing zinc-lead-silver mine at Maarrmorilik and the nearby Kangerluarsuk exploration licence, and the Minturn Iron Oxide Copper Gold prospect in northwest Greenland. The Company’s strategy is to unlock the resource potential in Greenland through the continued exploration and development of its wider portfolio, while building a responsible, full-cycle mining company, including through its Suliaq subsidiary, which provides mining services and logistics capabilities for Greenland’s developing mining sector, and Imeq ApS, Greenland’s first private hydroelectric project.

The Company is listed on the LSE and Nasdaq Iceland under the ticker AMRQ, and on OTCQX under AMRQF.

Reykjavík, Oct. 07, 2026 (GLOBE NEWSWIRE) —

(“Amaroq” or the “Company“)

Admission to Trading and PDMR Transaction

07 October 2026 – Amaroq Ltd. (LSE and NASDAQ Iceland: AMRQ, OTCQX: AMRQF), an independent mine development company focused on unlocking Greenland’s mineral potential, announces that, in accordance with the Financial Conduct Authority’s Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, the following shares have been admitted to trading:

Issuer name:  Amaroq Ltd.
Issuer LEI:  213800Q21S5JQ6WKCE70
Regulated market on which the shares have been admitted to trading: Main Market for listed securities of the London Stock Exchange
Name, type and ISIN of the shares:
 
Common shares of no par value
ISIN: CA02311U1030
Number of further shares admitted to trading covered by the notification: 147,879
Total number of shares admitted to trading (including the new shares):  466,392,011
Confirmation that the new shares are fungible with existing shares already admitted to trading:  Confirmed
Date range covered by the notification: 1 September 2026 to 6 October 2026

DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

The Company has been informed by Non-Executive Director Graham Stewart, that for personal reasons he has had to dispose of 1,000,000 shares. Graham remains a large shareholder, with 1,982,537 shares. Please find further detail below:

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name: Graham Stewart
2. Reason for the notification
a) Position/status: Non-Executive Director
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Amaroq Ltd.
b) LEI: 213800Q21S5JQ6WKCE70
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument:
Identification code:
Common shares of no par value in Amaroq Ltd.
ISIN: CA02311U1030
b) Nature of the transaction: Sale of common shares of no par value in Amaroq Ltd.
c) Price(s) and volume(s):            Price(s)         Volume(s)
121.5p                        1,000,000
d) Aggregated information:

  • Aggregated volume:
  • Average price:
            1,000,000
121.5p
e) Date of the transaction(s): 6 October 2026
f) Place of the transaction London Stock Exchange (XLON)

Enquiries:
Amaroq Ltd. C/O
Ed Westropp, Chief Corporate Development and Strategy Officer
+44 (0)7385 755711
ewe@amaroqminerals.com

Canaccord Genuity Limited (Corporate Broker)
James Asensio
Rory Blundell
Harry Rees
+44 (0) 20 7523 8000

Citigroup Global Markets (Corporate Broker)
Andrew Miller-Jones
David Herring
+44 (0) 207 986 3463

Panmure Liberum Limited (Corporate Broker)
Scott Mathieson
Piers Shimwell
+44 (0) 20 7886 2500

Camarco (Financial PR)
Elfie Harkell
Rebecca Waterworth
Charlie Ramos
+44 (0) 20 3757 4980

Further Information:

About Amaroq

Amaroq’s focus is the identification, acquisition, exploration and development of gold and strategic metals in Greenland. The Company’s principal asset is the 100% owned and operated, producing Nalunaq Gold mine.

Amaroq’s significant exploration portfolio includes opportunities in gold, copper, nickel, and rare earth elements across South Greenland as well as zinc, lead, silver, germanium and gallium at its West Greenland Hub centred on the past-producing zinc-lead-silver mine at Maarrmorilik and the nearby Kangerluarsuk exploration licence, and the Minturn Iron Oxide Copper Gold prospect in northwest Greenland. The Company’s strategy is to unlock the resource potential in Greenland through the continued exploration and development of its wider portfolio, while building a responsible, full-cycle mining company, including through its Suliaq subsidiary, which provides mining services and logistics capabilities for Greenland’s developing mining sector, and Imeq ApS, Greenland’s first private hydroelectric project.

The Company is listed on the LSE and Nasdaq Iceland under the ticker AMRQ, and on OTCQX under AMRQF.

Reformulated PC® Nutrition First® dry dog and cat food closes the gap between the grocery aisle and the specialty pet store. Its veterinarian-formulated recipes are available where Canadians already shop for their families, priced up to 40% less per 100g than select comparable dry dog and cat foods at pet specialty retailers* — no extra family errand required.

Pet Food Comparison Chart

BRAMPTON, Ontario, Oct. 07, 2026 (GLOBE NEWSWIRE) — Pets have a way of taking over the couch, the bed and most of the camera roll. Now, feeding them thoughtfully fits better into the family grocery run too.

President’s Choice® has reformulated its PC® Nutrition First® dry dog and cat food for Canadian pet parents who put just as much thought into what goes into their pet’s nutrition as they do the rest of their family. That’s why every PC® Nutrition First® dry dog and cat food recipe is veterinarian-formulated with real meat as the first ingredient with thoughtfully selected nutrients to support the things pet parents care about most—energy, healthy digestion, building blocks for strength, and a healthy coat.

Because what we leave out matters too, the recipes are formulated without artificial flavours or synthetic colours, animal by-products, corn, wheat or soy. Pet parents can also choose from options created for different life stages, breeds, sizes and nutritional needs.

It’s the ultimate mashup of pet specialty perks, grocery store convenience and price tags – all without having to give up on the nutritional benefits that pets deserve. PC® Nutrition First® is available in the grocery aisle for up to 40% less per 100g than select comparable dry dog and cat food at pet specialty retailers.*

“With four dogs and three cats at home, I know that great pet care comes down to quality, taste, and simplicity,” said April Preston, Senior Vice President Control Brand, Product Management & Innovation. “We reformulated PC® Nutrition First to make premium, veterinarian-formulated nutrition accessible in the grocery aisle, helping Canadian families nourish the pets they love without the extra errand or specialty price tag.”

One Family. One Grocery Run. Plenty of Choices.

Whether the household includes a new puppy, a small dog with a big personality or a cat with very particular preferences, the PC® Nutrition First® portfolio offers recipes created for a range of pets and needs:

  • The first ingredient is real meat: Every dry food recipe begins with real meat, providing essential amino acids from protein to support heart and eye health.
  • Different recipes for different family members: Options are available for different life stages, breeds, sizes and nutritional needs, including sensitive stomachs, skin and coat care, weight management and oral care.
  • Grain-free choices: Select recipes provide complete and balanced nutrition for pet parents looking for a grain-free option.
  • Everyday digestive health support: All recipes include prebiotics and probiotics to help support a healthy digestive tract.
  • Cognitive health support: Recipes are formulated with DHA or antioxidants to help support cognitive health.
  • Specially formulated: Recipes are formulated without artificial flavours or synthetic colours, animal by-products, corn, wheat or soy.

In other words, Canadians can put meaningful formulation features in the bowl without putting another stop on the calendar.

Ultimately, caring for pets like family means finding quality nutrition at a price you can feel good about. PC® is making the quality pet parents are looking for easier to find – and afford. The reformulated PC® Nutrition First® dry dog and cat food portfolio, along with a growing selection of treats, is available now at participating Loblaw banner stores across Canada and online at pcexpress.ca/pc-nutrition-first.

For more information and help finding the right recipe for your pet, visit pcexpress.ca/pc-nutrition-first.

DISCLAIMER:
*Based on average regular retail price per 100g of the brands shown in the chart. Prices may vary by store. See in-store or online at pcexpress.ca/pc-nutrition-first for details.

ABOUT LOBLAW COMPANIES LIMITED
Loblaw is Canada’s food and pharmacy leader, and the nation’s largest retailer. Loblaw provides Canadians with grocery, pharmacy, and healthcare services, other health and beauty products, apparel, general merchandise, financial services and wireless mobile products and services. With more than 2,800 locations, Loblaw, its franchisees and Associate-owners employ more than 220,000 full- and part-time employees, making it one of Canada’s largest private sector employers.

Loblaw’s purpose – Live Life Well® – puts first the needs and well-being of Canadians who make one billion transactions annually in the company’s stores. Loblaw is positioned to meet and exceed those needs in many ways: convenient locations; more than 1,100 grocery stores that span the value spectrum from discount to specialty; full-service pharmacies at nearly 1,400 Shoppers Drug Mart® and Pharmaprix® locations and in close to 500 grocery stores; PC Financial® services; Joe Fresh® fashion and family apparel; and four of Canada’s top-consumer brands in Life Brand®, Farmer’s Market™, no name® and President’s Choice®. For more information, visit Loblaw’s website at www.loblaw.ca and Loblaw’s issuer profile at www.sedarplus.ca

MEDIA CONTACT: Avery@themintagency.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bef75948-7ead-48fc-bfd7-79f942ab31c9

DANONE

French Société anonyme with a capital of €170,834,294.25
Registered Office: 59-61, rue La Fayette, 75009 Paris.
Registered with the Paris Commerce and Company Registry under number 552 032 534

Information on the total number of voting rights and shares

in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers)

Date Total number of shares Total number of voting rights
30/09/2026 683,337,177 Total number of theoretical voting rights(1): 723,250,283

Total number of exercisable voting rights(2): 684,008,600

(1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended.

(2) The total number of exercisable voting rights (or ”net” voting rights) is calculated without taking into account the shares with suspended voting rights. It is published to ensure that the public is properly informed in accordance with the recommendation made by the AMF on July 17, 2007.

Attachment

Final three quick move-in homes with rare views and personalization options available

WASHOUGAL, Wash., Oct. 07, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity for home shoppers to purchase one of the three remaining quick move-in homes at Bluffs at Granite Highlands, a luxury community in Washougal, Washington. These homes feature sweeping water and mountain views, rare in the region, along with the opportunity for personalization and move-in dates in early 2027. Homes are priced from $1.6 million.

Perched above the Columbia River, Bluffs at Granite Highlands offers estate-style homes with modern architecture in a gated neighborhood. Expansive home designs range from 3,844 to 4,430 square feet, featuring 5 to 6 bedrooms, 4.5 to 5.5 baths, and 3-car garages. Select homes include daylight basements, lofts, flex rooms, and first-floor bedrooms, allowing home shoppers to choose a home that fits their lifestyle.

Bluffs at Granite Highlands by Toll Brothers

“Bluffs at Granite Highlands is a truly one-of-a-kind opportunity to own a new luxury home in a stunning location,” said Mike Grubbe, Division President of Toll Brothers in Oregon and Southwest Washington. “With breathtaking views and just three quick move-in homes remaining, we encourage home shoppers to take advantage of this last chance to own a new home personalized to their style in this unparalleled community.”

Home shoppers will experience one-stop shopping at the Toll Brothers Design Studio. The state-of-the-art Design Studio allows home shoppers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants.

Bluffs at Granite Highlands by Toll Brothers

Bluffs at Granite Highlands is conveniently located near downtown Camas, known for its small-town charm and vibrant shops and eateries, as well as outdoor recreation opportunities such as Lacamas Lake Park and Woodburn Falls. The community offers the tax advantages of living in Washington State while remaining close to Portland, Oregon and Vancouver, Washington. Portland International Airport is just a 20-minute drive away.

The Bluffs at Granite Highlands Sales Center is located at 486 N. Y Street in Washougal. For more information, call Toll Brothers at 844-900-8655 or visit TollBrothers.com/WA.

About Toll Brothers

Toll Brothers, Inc., a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded in 1967 and became a public company in 1986 with common stock listed on the New York Stock Exchange under the symbol “TOL.” Toll Brothers builds new homes and communities in over 60 markets across the United States, serving first-time, move-up, active-adult, and second-home buyers. The Company also operates its own architectural, engineering, mortgage, title, land development, smart home technology, landscape, and building components manufacturing businesses.

Toll Brothers was named the #1 Most Admired Home Builder in Fortune magazine’s 2026 list of the World’s Most Admired Companies®, the ninth year the Company has achieved this honor. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com.

From Fortune, ©2026 Fortune Media IP Limited. All rights reserved. Used under license.

Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | ameck@tollbrothers.com

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a5e28ad1-c201-4771-90a0-4960a7dd8490
https://www.globenewswire.com/NewsRoom/AttachmentNg/56c6842a-0f0c-4c99-bd6e-5aa675cf96a4

Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)

Company Announcement
COPENHAGEN, Denmark; October 7, 2026 – Genmab A/S (Nasdaq: GMAB) 
Today, Genmab A/S held an Extraordinary General Meeting.
At the Extraordinary General Meeting the proposal from the Board of Directors on remuneration of the Board of Directors for 2026, including share-based remuneration in the form of restricted stock units, was approved.

As a result of the adoption of the proposal, a total of 5,300 restricted stock units were granted to the members of the Board of Directors in accordance with Genmab A/S’ Remuneration Policy.

Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price of one Genmab A/S share on the date of grant, DKK 2,487.00.

The restricted stock units will vest on the first banking day of the month following a period of three years from the date of grant and are otherwise subject to the terms and conditions set out in Genmab A/S’ Remuneration Policy and the applicable restricted stock unit program.

Information concerning Genmab’s restricted stock unit program can be found on www.genmab.com under Investors > Governance > Compensation > Restricted Stock Units. Genmab’s Remuneration Policy is accessible via this link Compensation | Genmab.

About Genmab 
Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. For over 25 years, its passionate, innovative and collaborative team has advanced a broad range of antibody-based therapeutic formats, including bispecific antibodies, antibody–drug conjugates (ADCs), immune-modulating antibodies and other next-generation modalities. Genmab’s science powers eight approved antibody medicines, and the company is advancing a strong late-stage clinical pipeline, including wholly owned programs, with the goal of delivering transformative medicines to patients.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn, X, Facebook and Instagram.

Contact:        
Marisol Peron, Senior Vice President, Global Communications & Corporate Affairs
T: +1 609 524 0065; E: mmp@genmab.com

Andrew Carlsen, Vice President, Head of Investor Relations
T: +45 3377 9558; E: acn@genmab.com

This Company Announcement contains forward looking statements. The words “believe,” “expect,” “anticipate,” “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.

Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; HexaBody®; DuoHexaBody®, HexElect® and KYSO®.

Company Announcement no. 41
CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122

Genmab A/S
Carl Jacobsens Vej 30
2500 Valby
Denmark

Attachment

Amsterdam, October 7, 2026

SBM Offshore reports the transaction details related to its EUR227 million (US$270 million1) share repurchase program for the period October 1, 2026 through October 7, 2026.

The repurchases were made under the EUR227 million share repurchase program announced on February 26, 2026 and effective from February 27, 2026. The objective of the program is to reduce share capital and, in addition, to provide shares for regular management and employee share programs. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period February 27, 2026 through October 7, 2026 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Company’s website.

Share Repurchase Program    
       
Overall progress Share Repurchase Program:    
         
Total Repurchase Amount   EUR 226,633,158  
Cumulative Repurchase Amount   EUR 139,760,027  
Cumulative Quantity Repurchased   4,110,166  
Cumulative Average Repurchase Price   EUR 34.00  
Start Date     February 27, 2026  
Percentage of program completed as of October 7, 2026 61.67%  
         
Overview of details of last 5 trading days:    
         
Trade Date Quantity Repurchased Average Purchase Price Settlement Amount  
October 1, 2026 25,923 EUR 34.56 EUR 895,997  
October 2, 2026 25,984 EUR 34.48 EUR 895,983  
October 5, 2026 25,672 EUR 34.90 EUR 895,994  
October 6, 2026 25,585 EUR 35.02 EUR 895,989  
October 7, 2026 25,544 EUR 35.08 EUR 895,971  
Total 128,708 EUR 34.81 EUR 4,479,935  

All shares purchased via Euronext Amsterdam, CBOE DXE, Turquoise Europe and or Aquis Europe.

This press release contains information which is to be made publicly available under the Market Abuse Regulation (nr. 596/2014). The information concerns a regular update of the transactions conducted under SBM Offshore’s current share repurchase program, as announced by the Company on February 26, 2026, details of which are available on its website.

Corporate Profile

SBM Offshore is a global leader in deepwater ocean infrastructure, delivering floating production solutions across the full asset lifecycle—from design and construction to installation and operation. Supported by a global team of more than 8,000 professionals, the Company operates a long-term, asset-backed business model that delivers high-availability assets and predictable cash flows. SBM Offshore combines engineering expertise, operational reliability, and selective innovation to support safe, efficient, and lower-carbon energy production, while extending its capabilities into new opportunities across the blue economy.

For further information, please visit our website at www.sbmoffshore.com.

Financial Calendar   Date Year
Third Quarter 2026 Trading Update   November 12 2026
Full Year 2026 Earnings   February 18 2027
Annual General Meeting   April 7 2027
First Quarter 2027 Trading Update   May 5 2027
Half Year 2027 Earnings   August 5 2027

For further information, please contact:

Investor Relations
Wouter Holties
Corporate Finance & Investor Relations Manager

Mobile: +31 (0) 2 02 36 32 36
E-mail: wouter.holties@sbmoffshore.com
Website: www.sbmoffshore.com

Media Relations

Giampaolo Arghittu
Head of External Relations

Phone: +31 (0) 6 212 62 333 / +39 33 494 79 584
E-mail: giampaolo.arghittu@sbmoffshore.com
Website: www.sbmoffshore.com

Market Abuse Regulation

This press release may contain inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

Disclaimer

Some of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on management’s current views, expectations and various assumptions regarding the financial and non-financial position of SBM Offshore N.V., anticipated developments and other factors, and involve known and unknown risks, dependencies and uncertainties that could cause actual results, performance, or events to differ materially from those in such statements. These statements may be identified by words such as ‘expect’, ‘should’, ‘could’, ‘shall’ and / or similar expressions. Such forward-looking statements are subject to various risks and uncertainties. The principal risks which could affect the future operations of SBM Offshore N.V. are described in the ‘Impacts, Risks and Opportunities’ section of the 2025 Annual Report.

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results and performance of the Company’s business may vary materially and adversely from the forward-looking statements described in this release. SBM Offshore N.V. does not intend and does not assume any obligation to update any industry information or forward-looking statements set forth in this release to reflect new information, subsequent events or otherwise.

Data underpinning certain disclosures – particularly sustainability-related – may be subject to inherent limitations. These limitations include but are not limited to reliance on third party data providers whose data quality, completeness and integrity may differ; the use of estimates and assumptions where actual data is unavailable or incomplete; and dependencies on value chain partners for timely and accurate information provision. Methodologies, standards and regulatory requirements for measuring and reporting information—especially sustainability related information—continue to evolve. As a result, our measurement approaches and reported figures may be refined over time as more accurate, granular or standardized data becomes available. Accordingly, all data, and emissions data in particular, should be interpreted in light of these limitations and the ongoing maturation of sustainability reporting practices across our value chain.

This release contains certain alternative performance measures (APMs) as defined by the ESMA guidelines which are not defined under IFRS. Further information on these APMs is included in the Half Year Management Report accompanying the Half Year Earnings 2026 report, available on our website Half Year Earnings – SBM Offshore.

Nothing in this release shall be deemed an offer to sell, or a solicitation of an offer to buy, any securities. The companies in which SBM Offshore N.V. directly and indirectly owns investments are separate legal entities. In this release “SBM Offshore” and “SBM” are sometimes used for convenience where references are made to SBM Offshore N.V. and its subsidiaries in general. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

“SBM Offshore®“, the SBM logomark, “Fast4Ward®”, and “F4W®” and “Imodco®” are proprietary trade marks owned by SBM Offshore.


1 Based on the EUR/US$ forward exchange rate on February 18, 2026.

Attachment

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.